(Press-News.org) BOSTON (Nov. 23, 2010) —Breast cancer stem cells (CSCs), the aggressive cells thought to be resistant to current anti-cancer therapies and which promote metastasis, are stimulated by estrogen via a pathway that mirrors normal stem cell development. Disrupting the pathway, researchers were able to halt the expansion of breast CSCs, a finding that suggests a new drug therapy target. The study, done in mice, is published in the Proceedings of the National Academy of Sciences (PNAS) Early Edition this week.
"A critical aspect of our work was to discover that estrogen could promote breast cancer growth by modulating the proportion of breast CSCs. Since CSCs were not directly sensitive to estrogen, it wasn't clear how estrogen could affect their numbers. However, we found that hormone-sensitive cancer cells can communicate with CSCs to regulate their numbers. By disrupting the interaction between cancer cell populations we were able to prevent tumor growth," said Charlotte Kuperwasser, PhD, associate professor in the anatomy and cellular biology and radiation oncology departments at Tufts University School of Medicine, and member of the genetics and cell, molecular & developmental biology program faculties at the Sackler School of Graduate Biomedical Sciences at Tufts.
"Interestingly, this signaling pathway involves many of the same players that control normal stem cell biology, raising a more general possibility that CSCs in other tumors might be regulated by the mechanisms guiding normal development," said Kuperwasser.
Kuperwasser and colleagues from MIT and Harvard used a mouse model to examine the behavior of cancerous human breast tissue with a method that mimics the human body more closely than standard mouse models. The researchers first examined estrogen's effect on breast CSC growth, finding that estrogen caused breast CSC numbers to increase by nearly 800 percent. Since few breast CSCs contain estrogen receptors, the researchers suspected that estrogen's actions were through a signaling mechanism from nearby cells that express the receptors.
"When nearby cells were exposed to estrogen, they secreted 14 times more FGF9, a signaling protein that drives CSC proliferation. When we blocked the FGF pathway with a small molecule inhibitor, we saw loss of CSC growth, tumorspheres generation, and even tumor formation. We then linked FGF signaling to the Tbx3 signaling axis, which is also important for embryonic mammary gland development," said first author Christine Fillmore, PhD, a 2009 graduate of the genetics program at the Sackler School and currently a research fellow in genetics at Children's Hospital Boston.
"These results show that interfering with this signaling pathway is a promising strategy for targeting breast CSCs. We are hopeful that the improved understanding of the mechanisms that promote breast CSCs will lead to the development of drugs that can be used to halt CSC proliferation," said Kuperwasser.
Kuperwasser also leads a laboratory at the Molecular Oncology Research Institute (MORI) at Tufts Medical Center, which is dedicated to the exploration of the molecular mechanisms of cancer and the translation of findings into the clinic.
INFORMATION:
Additional authors on the study include Piyush Gupta, PhD, formerly of the Broad Institute, and now a member of the Whitehead Institute for Biomedical Research as well as an assistant professor of biology at MIT; Jenny Rudnick, a graduate student in the cell, molecular & developmental biology program at the Sackler School and member of the Kuperwasser lab at MORI; Silvia Caballero, formerly a participant in the Post-baccalaureate Research Education Program at the Sackler School, and now at Cornell University; Patricia Keller, PhD, a postdoctoral fellow in the department of anatomy and cellular biology at TUSM and member of Kuperwasser's lab at MORI; and Eric Lander, PhD, founding director of the Broad Institute, professor of biology at MIT, and professor of systems biology at Harvard Medical School.
This study was supported by the Breast Cancer Research Foundation, the Raymond and Beverly Sackler Foundation, and by the National Cancer Institute, part of the National Institutes of Health; and by a Broadway on Beachside Postdoctoral Fellowship from the New England Division of the American Cancer Society to Patricia Keller.
The Post-baccalaureate Research Education Program at the Sackler School is funded through the Division of Minority Opportunities in Research program of the National Institute of General Medical Sciences, an institute of the National Institutes of Health, and by the Sackler School.
Fillmore CM, Gupta PB, Rudnick JA, Caballero S, Keller PJ, Lander ES, and Kuperwasser C. PNAS Early Edition. "Estrogen expands breast cancer stem-like cells through paracrine FGF/Tbx3 signaling." Published online November 22, 2010 , doi:10.1073/pnas.1007863107
About Tufts University School of Medicine and the Sackler School of Graduate Biomedical Sciences
Tufts University School of Medicine and the Sackler School of Graduate Biomedical Sciences at Tufts University are international leaders in innovative medical education and advanced research. The School of Medicine and the Sackler School are renowned for excellence in education in general medicine, biomedical sciences, special combined degree programs in business, health management, public health, bioengineering and international relations, as well as basic and clinical research at the cellular and molecular level. Ranked among the top in the nation, the School of Medicine is affiliated with six major teaching hospitals and more than 30 health care facilities. Tufts University School of Medicine and the Sackler School undertake research that is consistently rated among the highest in the nation for its effect on the advancement of medical science.
If you are a member of the media interested in learning more about this topic, or speaking with a faculty member at the Tufts University School of Medicine, the Sackler School of Graduate Biomedical Sciences, or another Tufts health sciences researcher, please contact Siobhan Gallagher at 617-636-6586.
END
ARLINGTON, VA-- NOVEMBER 23, 2010 - - CONRAD is pleased to join in congratulating the Global iPrEx study team for their successful trial of oral tenofovir (TDF) with emtricitabine (FTC) for HIV prevention. Results of the National Institutes of Health (NIH) sponsored study were announced today in the New England Journal of Medicine. Daily use of the widely used antiretroviral combination pill was found to be an average of 44% effective in reducing risk of HIV infection in men who have sex with men (MSM), a historically high risk population. Among participants who took ...
If you're lucky, it will all be kisses and hugs around the Thanksgiving dinner table, with friends and family near and dear gathered about, and puppies gathered around your feet waiting for table scraps.
But peace won't reign within the confines of the oral cavity, where Streptococcus mutans and other harmful bacteria will await their own holiday feast. Your meal will enable S. mutans to launch one of its biggest assaults of the year on your tooth enamel.
New work by dental researchers at the University of Rochester Medical Center brings both good and bad news. While ...
In many developing countries, forest restoration at home has led to deforestation abroad, according to a new study in the Proceedings of the National Academy of Sciences (PNAS).
The authors say their findings could have significant implications for ongoing efforts to protect the world's remaining forests, which are disappearing at an annual rate of more than 32 million acres – an area roughly the size of England.
"Reducing deforestation is an international priority, given its impacts on carbon emissions and biodiversity," said study co-author Eric Lambin of Stanford ...
Ask the Eucalyptus connoisseurs
Koalas may be the pickiest marsupials around: They evolved to feed almost exclusively on the leaves of Eucalyptus trees, and they are highly selective when it comes to which species and even which individual trees they visit. When the furry leaf-eater settles on a particular tree, it relies on a number of factors, including taste, to make its selection. In a study published in the November issue of Ecology, a journal of the Ecological Society of America (ESA), researchers used koala feeding preferences to design a new method that could help ...
Fuel cells could create a breakthrough for electric cars, because refuelling them is fast and easy, just like your traditional gas guzzler. But there's an obstacle. Current fuel cells need platinum in order to work. And that's expensive.
Now chemists from Copenhagen, Potsdam and Hanau have taken the first step towards producing fuel cells using very little of the precious metal.
At the University of Copenhagen Matthias Arenz has specialized in testing the catalysts that do the actual work in fuel cells. Presented with a so called "Core Shell catalyst" developed by Clarkson ...
NEW YORK (Nov. 23, 2010) -- A hormone made by the body may be a potential therapeutic tool for the treatment of two anemic blood disorders -- beta-thalassemia and hemochromatosis. The new research was led by scientists at Weill Cornell Medical College and published in the Journal of Clinical Investigation and the journal Blood.
Commonly known as Cooley's anemia, beta-thalassemia affects nearly 1,000 individuals in the United States; worldwide, approximately 300,000 children are born each year with thalassemias. The conditions cause excessive iron absorption in the body's ...
BATON ROUGE – LSU Professor Edward Shihadeh and Ph.D. candidate Raymond Barranco recently published a study titled "Latino Immigration, Economic Deprivation and Violence: Regional Differences in the Effect of Linguistic Isolation" in the journal Homicide Studies.
The researchers found that when Latinos in the United States lack English language capability, they are far more likely to be murdered. But this link between English language proficiency and victimization exists only in places where Latinos have settled recently – in places that the authors term "new Latino destinations." ...
WASHINGTON — Earth and space science missions developed and implemented by federal agencies in collaboration typically result in additional complexity and cost and increased risks from divided responsibilities and accountability, says a new report from the National Research Council. Federal agencies should not partner in conducting space and earth science missions unless there is a compelling reason to do so and clear criteria are met in advance.
"A common misperception among policymakers and individual agencies is that collaboration on these missions will save money ...
23 November 2010 (Geneva, Switzerland) – The International AIDS Society (IAS) cautiously notes the comments from Pope Benedict that condom use could, in specific circumstances, be acceptable, but calls on the Pope and the Catholic Church to come out clearly and strongly in support of all evidence-based methods of HIV prevention, including condom use.
By implying that there can only be some exceptional circumstances that could allow for condom usage, such as that of male prostitutes, the Pope is ignoring scientific evidence that shows that both male and female condoms, ...
November 23, 2010 – Geneva, Switzerland – The International AIDS Society (IAS) calls on the Burmese Government to reverse a ruling made on November 18 to shut down a charitable HIV/AIDS clinic in Rangoon. The government demand came just one day after Aung San Suu Kyi, the recently released Nobel Peace Prize laureate visited the centre to show her support.
The clinic known as the HIV/AIDS Patients Care Center has been given up to November 25 to close. The Burmese Government has repealed the clinic's permit as well as refusing to renew residence permits to the 80 patients ...
